Shanghai Shyndec Pharmaceutical Co., Ltd. Current Ratio for the year ending December 31, 2024: 2.69

Shanghai Shyndec Pharmaceutical Co., Ltd. Current Ratio is 2.69 for the year ending December 31, 2024, a -4.60% change year over year. Current ratio represents the short-term liquidity measurement, showing current assets' coverage of liabilities. Higher ratio implies better ability to meet short-term obligations.
  • Shanghai Shyndec Pharmaceutical Co., Ltd. Current Ratio for the year ending December 31, 2023 was 2.82, a 1.24% change year over year.
  • Shanghai Shyndec Pharmaceutical Co., Ltd. Current Ratio for the year ending December 31, 2022 was 2.78, a 75.05% change year over year.
  • Shanghai Shyndec Pharmaceutical Co., Ltd. Current Ratio for the year ending December 31, 2021 was 1.59, a -3.02% change year over year.
  • Shanghai Shyndec Pharmaceutical Co., Ltd. Current Ratio for the year ending December 31, 2020 was 1.64, a 10.07% change year over year.
Key Data
Date Current Ratio Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE)